These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1114478)

  • 21. Plasma assay of fetal factors VIIIC and IX for prenatal diagnosis of haemophilia.
    Mibashan RS; Rodeck CH; Thumpston JK; Edwards RJ; Singer JD; White JM; Campbell S
    Lancet; 1979 Jun; 1(8130):1309-11. PubMed ID: 87775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editorial: Haemophilia in women.
    Lancet; 1973 Dec; 2(7841):1305-6. PubMed ID: 4127650
    [No Abstract]   [Full Text] [Related]  

  • 23. Lyonization in hemophilia: a cause of error in direct detection of heterozygous carriers.
    Graham JB; Barrow ES; Elston RC
    Ann N Y Acad Sci; 1975 Jan; 240():141-6. PubMed ID: 1053859
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of stanozolol on factors VIII and IX and serum aminotransferases in haemophilia.
    Greer IA; Greaves M; Madhok R; McLoughlin K; Porter N; Lowe GD; Preston FE; Forbes CD
    Thromb Haemost; 1985 Jun; 53(3):386-9. PubMed ID: 3931287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemophilia treatment in the United Kingdom from 1969 to 1974.
    Biggs R
    Br J Haematol; 1977 Apr; 35(4):487-504. PubMed ID: 871406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methods for the detection of haemophilia carriers: a memorandum.
    Bull World Health Organ; 1977; 55(6):675-702. PubMed ID: 304395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factor levels in carriers of haemophilia are associated with familial severity: a Danish single centre study.
    Funding E; Christiansen K; Poulsen LH
    Haemophilia; 2015 Sep; 21(5):e440-2. PubMed ID: 26178416
    [No Abstract]   [Full Text] [Related]  

  • 28. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
    Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Determination of prothromboplastin factors (Factors VIII, IX, XI and XII)].
    Kagami M
    Nihon Rinsho; 1976; 34 suppl():2407-24. PubMed ID: 792517
    [No Abstract]   [Full Text] [Related]  

  • 30. Association of factor VIII and factor IX mutations, HLA Class II, tumour necrosis factor-α and interleukin-10 on inhibitor development among Thai haemophilia A and B patients.
    Chuansumrit A; Sasanakul W; Sirachainan N; Kadegasem P; Wongwerawattanakoon P; Mahaklan L; Nathalang O
    Haemophilia; 2017 Nov; 23(6):e518-e523. PubMed ID: 28891589
    [No Abstract]   [Full Text] [Related]  

  • 31. [An unified method of one-stage quantitative analysis of factors VIII and IX. I. (Results of the studies of the working group of the All-Union Problem-Solving Commission on "Pathology of hemostasis")].
    Barkagan ZS
    Gematol Transfuziol; 1991 Apr; 36(4):33-5. PubMed ID: 1906034
    [No Abstract]   [Full Text] [Related]  

  • 32. Haemophilia in the newborn. A case report and literature review.
    Koch JA
    S Afr Med J; 1978 May; 53(18):721-2. PubMed ID: 358419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The predictive value of factor VIII/factor IX levels to define the severity of hemophilia: communication from the SSC of ISTH.
    Mancuso ME; Bidlingmaier C; Mahlangu JN; Carcao M; Tosetto A;
    J Thromb Haemost; 2018 Oct; 16(10):2106-2110. PubMed ID: 30182468
    [No Abstract]   [Full Text] [Related]  

  • 34. Surgery in children with congenital disorders of blood coagulation.
    Dudley NE; Kernoff PB; Gough MH
    J Pediatr Surg; 1971 Dec; 6(6):689-701. PubMed ID: 5316141
    [No Abstract]   [Full Text] [Related]  

  • 35. Carrier detection and prenatal diagnosis in families with haemophilia.
    Shetty S; Ghosh K; Bhide A; Mohanty D
    Natl Med J India; 2001; 14(2):81-3. PubMed ID: 11396323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The comparison of CS-2500 and BCS XP coagulation analyzers for Factor VIII and Factor IX one-stage clotting assays.
    Genc S; Aydin AF; Karaca E; Ömer B
    Int J Lab Hematol; 2019 Oct; 41(5):e124-e127. PubMed ID: 31034727
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intragenic polymorphisms of factor VIII and IX genes and their utility in the indirect diagnosis of carriers of Haemophilias A and B].
    Borjas L; Zabala W; Pineda L; Pardo T; Fernández E; Zambrano M; Quintero JM; Arteaga-Vizcaíno M; Morales-Machín A; Delgado W
    Invest Clin; 2010 Sep; 51(3):391-401. PubMed ID: 21305775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of carriers of haemophilia B.
    Orstavik KH; Veltkamp JJ; Bertina RM; Hermans J
    Br J Haematol; 1979 Jun; 42(2):293-301. PubMed ID: 465373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemophilia and von Willebrand's disease: genetic considerations.
    Green D
    Ann Clin Lab Sci; 1980; 10(2):123-7. PubMed ID: 6770741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of phospholipid on factor VIII inactivation.
    Barrowcliffe TW; Kemball-Cook G; Gray E
    Prog Clin Biol Res; 1984; 150():251-63. PubMed ID: 6431431
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.